
Significance of Biosimilars in Treatment of Multiple Myeloma
Biosimilars are a copy of the original biologic medical product used in the treatment of a particular disease. These are also known as follow-on or subsequent entry biologics. Biosimilars are officially approved versions of the original “innovator” medicines and are manufactured by a different pharmaceutical company. However, biosimilars can be manufactured only after the patent of the original biologic expires.
Read More